Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Home-based exercise program for patients with pulmonary embolism

Official title: Mobility Outcomes in Post-Pulmonary Embolic Disease (MOPED): A Pilot Feasibility Prospective Randomized Trial

Run by Mayo Clinic · NCT06695247 · Data updated 2026-11-12

This study is testing a home-based exercise program to help people recovering from pulmonary embolism improve their mobility and overall health.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment100 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedJuly 14, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedAugust 10, 2026
Trial IDNCT06695247 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with acute intermediate-risk or high-risk pulmonary embolism who exhibit specific imaging characteristics.

Probably not a fit

Patients with chronic pulmonary conditions or those not meeting the acute pulmonary embolism criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve mobility outcomes for patients recovering from pulmonary embolism by implementing a home-based exercise program. The program is designed through the collaboration of cardiovascular medicine specialists and cardiac physiologists, utilizing an Interactive Care Plan to guide patients in their rehabilitation. Participants will engage in structured exercise training tailored to their specific needs and conditions. The study focuses on patients with acute intermediate-risk and high-risk pulmonary embolism, as identified through imaging techniques.

Why it matters

Potential benefit: If successful, this program could enhance recovery and mobility for patients suffering from pulmonary embolism.

How similar studies have gone: Other studies have shown positive outcomes with home-based exercise interventions for similar conditions, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Acute intermediate-risk PE, defined as:

* Intraluminal filling defect in segmental or larger vessels on computed tomography pulmonary angiography or high-probability ventilation/perfusion scan AND
* Evidence of right ventricular enlargement by computed tomography (RV to LV ratio \>1) or echocardiography; and/or right ventricular dysfunction by transthoracic echocardiography. These imaging characteristics must be in the setting of acute PE rather than explained by a prior chronic condition.

Acute high-risk PE, defined as:

* Intraluminal filling defect in segmental or larger vessels on computed tomography pulmonary angiography or high-probability ventilation/perfusion scan AND
* Evidence of right ventricular enlargement by computed tomography (RV to LV ratio \>1) or echocardiography; and/or right ventricular dysfunction by transthoracic echocardiography. These imaging characteristics must be in the setting of acute PE rather than explained by a prior chronic condition; AND
* Hypotension (systolic blood pressure \< 90 mm Hg sustained for more than 15 minutes; or requiring vasopressors) or cardiogenic shock due to acute pulmonary embolism.

Exclusion Criteria:

* Inability to ambulate independently, which is necessary to perform 6MWD (may be self-reported or as deemed by physical therapy during inpatient evaluation).
* If patient requires supplemental oxygen during ambulation, this does not exclude patient from participation and will be noted during eCRF.
* Prior history of pulmonary embolism
* History of CTEPH or pulmonary arterial hypertension
* Unable to read a questionnaire in English
* Unable to return for baseline, 3- or 6-month follow-up visit
* Pregnancy-associated pulmonary embolism
* Life expectancy \<1 year based on comorbidities
* Unable/unwilling to provide informed written consent

Where it's running

  • Mayo Clinic Rochester
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.